Breelyn Wilky, MD, discusses what key molecular insights in GIST management community oncologists should prioritize today.

Imatinib has become standard therapy in patients newly diagnosed with chronic-phase CML who are not candidates for allogeneic stem-cell transplantation, but long-term data are not available.

Thailand has taken a major step in its healthcare journey as the Chulabhorn Royal Academy (CRA) launches Imcranib 100 for ...

Ponatinib improved MRD negativity and safety in Ph+ ALL patients in the PHALLcon study, supporting its role as a potent TKI ...

Italy’s Robin Foà, MD, an iconic European clinician-researcher, has been at forefront of hematology’s transformation for half ...

Cancer is a class of diseases characterized by out-of-control cell growth, which are the building blocks of the body. Imatinib, known by its brand-Gleevec, is a type of biological therapy called ...

Cogent Biosciences, Inc. is a Strong Buy after trial data for bezuclastinib & market growth potential in systemic ...

"Imcranib 100", the first targeted cancer drug in tablet form developed and produced in Thailand, is the result of the ...

Thailand has produced its first locally developed targeted therapy pill for cancer treatment. Imcranib 100 is the result of ...

Thailand has introduced its first domestically created targeted therapy pill for cancer treatment, named Imcranib 100.

Aussies could be left hundreds of dollars out-of-pocket as Donald Trump threatens 200 per cent tariffs on Australian ...